Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Curis Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 40 | 42 | +2 |
| Shares | 4.67M | 4.29M | −381.3K (−8.2%) |
| Value | $9.80M | $9.84M | +$33.5K (+0.3%) |
New holders (5)
Institutions that held Curis Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 50,167 | $116.4K | 0.00% |
| Citadel Advisors LLC | 41,958 | $97.3K | 0.00% |
| Two Sigma Securities, LLC | 16,133 | $37.4K | 0.00% |
| Raymond James Financial Inc | 1,053 | $2.44K | 0.00% |
| BNP Paribas Arbitrage, SA | 5 | $12 | 0.00% |
Sold out (3)
Institutions that held Curis Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Alyeska Investment Group, L.P. | 189,377 | $397.7K |
| Samsara BioCapital, LLC | 185,943 | $390.5K |
| XTX Topco Ltd | 12,941 | $27.2K |